Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease
Open Access
- 28 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (8) , 5083-5101
Abstract
Motor neuron disease (MND) is a rapidly progressive condition traditionally assessed using a questionnaire to evaluate physical function, the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R). Its use can be associated with poor sensitivity in detecting subtle changes over time and there is an urgent need for more sensitive and specific outcome measures. The ActiGraph GT9X is a wearable device containing multiple sensors that can be used to provide metrics that represent physical activity. The primary aim of this study was to investigate the initial suitability and acceptability of limb-worn wearable devices to group of people with MND in Scotland. A secondary aim was to explore the preliminary associations between the accelerometer sensor data within the ActiGraph GT9X and established measures of physical function. 10 participants with MND completed a 12-week schedule of assessments including fortnightly study visits, both in-person and over videoconferencing software. Participants wore the device on their right wrist and right ankle for a series of movements, during a 6-min walking test and for a period of 24-h wear, including overnight. Participants also completed an ALSFRS-R and questionnaires on their experience with the devices. 80% of the participants found wearing these devices to be a positive experience and no one reported interference with daily living or added burden. However, 30% of the participants experienced technical issues with their devices. Data from the wearable devices correlated with established measures of physical function.Keywords
Funding Information
- Euan MacDonald Centre for Motor Neuron Disease Research
This publication has 35 references indexed in Scilit:
- Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational StudyJMIR mHealth and uHealth, 2019
- Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort studyJournal of Neurology, 2019
- Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in ScotlandAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2019
- Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALSFrontiers in Neurology, 2019
- ALS longitudinal studies with frequent data collection at home: study design and baseline dataAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2018
- “Anything that makes life’s journey better.” Exploring the use of digital technology by people living with motor neurone diseaseAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2017
- Nonmotor Symptoms in Amyotrophic Lateral Sclerosis: A Systematic Review2017
- What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2016
- How common are ALS plateaus and reversals?Neurology, 2016
- The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onsetAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2016